• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Spectrin beta chain, brain 3 (SPTBN4), Truncated

ACP11006

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP11006 Target NameSPTBN4
Target Synonymsbeta, Beta-IV spectrin; brain 3; KIAA1642; non-erythroid beta chain 3; QV; Spectrin; Spectrin beta chain; spectrin, non-erythrocytic 4; spectrin, non-erythroid beta chain 3; SPNB4; SPTBN3; SPTBN4; SPTN4_HUMANFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9H254
Background Information
  • Uniprot Id

    Q9H254

  • Target Species

    Human

  • Target Name

    SPTBN4

  • Target Full Name

    Spectrin beta chain, non-erythrocytic 4

  • Target Involvement

    Myopathy, congenital, with neuropathy and deafness (CMND)

  • Target Subcellular Location

    Cytoplasm, cytoskeleton. Cytoplasm, cell cortex.

  • Target Protein Families

    Spectrin family

  • Target Tissue Specificity

    Expressed in skeletal muscle at the sarcolemma and in the muscle capillaries (at protein level). Abundantly expressed in brain and pancreatic islets.

  • Target Synonyms

    Beta-IV spectrin; brain 3; KIAA1642; non-erythroid beta chain 3; QV; Spectrin; Spectrin beta chain; spectrin, beta, non-erythrocytic 4; spectrin, non-erythroid beta chain 3; SPNB4; SPTBN3; SPTBN4; SPTN4_HUMAN

Inquire Recombinant Human Spectrin beta chain, brain 3 (SPTBN4), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification